Supreme Court Endorses “Holistic” Approach to Evaluating Securities Fraud in Tellabs


Supreme Court Endorses “Holistic” Approach to Evaluating Securities Fraud in Tellabs

The Supreme Court has issued its much-anticipated decision in Tellabs v. Makor Issues & Rights, No. 06-484,

551 U.S. ___ (June 21, 2007). Tellabs holds that a court must consider competing inferences in determining

whether the allegations in a securities fraud complaint give rise to a “strong inference” of scienter, as required

by the heightened pleading standard set forth in the Private Securities Litigation Reform Act of 1995 (the

“Reform Act”). Congress imposed the heightened pleading requirement as a check against abusive litigation in

private securities fraud actions. While Tellabs provides guidance about what constitutes a “strong inference” of scienter, it rejects any brightline rules.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.